These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

216 related items for PubMed ID: 10896767

  • 1. Dual role of B cells in mediating innate and acquired immunity to herpes simplex virus infections.
    Deshpande SP, Kumaraguru U, Rouse BT.
    Cell Immunol; 2000 Jun 15; 202(2):79-87. PubMed ID: 10896767
    [Abstract] [Full Text] [Related]

  • 2. Establishment of latent herpes simplex virus type 1 infection in resistant, sensitive, and immunodeficient mouse strains.
    Ellison AR, Yang L, Voytek C, Margolis TP.
    Virology; 2000 Mar 01; 268(1):17-28. PubMed ID: 10683323
    [Abstract] [Full Text] [Related]

  • 3. Interleukin-12- and gamma interferon-dependent innate immunity are essential and sufficient for long-term survival of passively immunized mice infected with herpes simplex virus type 1.
    Vollstedt S, Franchini M, Alber G, Ackermann M, Suter M.
    J Virol; 2001 Oct 01; 75(20):9596-600. PubMed ID: 11559791
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Redundancy in the immune system restricts the spread of HSV-1 in the central nervous system (CNS) of C57BL/6 mice.
    Kastrukoff LF, Lau AS, Takei F, Smyth MJ, Jones CM, Clarke SR, Carbone FR.
    Virology; 2010 May 10; 400(2):248-58. PubMed ID: 20199790
    [Abstract] [Full Text] [Related]

  • 8. Resistance to herpetic stromal keratitis in immunized B-cell-deficient mice.
    Daheshia M, Deshpande S, Chun S, Kuklin NA, Rouse BT.
    Virology; 1999 Apr 25; 257(1):168-76. PubMed ID: 10208930
    [Abstract] [Full Text] [Related]

  • 9. Kinetics of primary and memory cytotoxic T lymphocyte responses to herpes simplex virus 1 infection: granzyme B mediated CTL activity.
    Gorgian Mohammadi M, Bamdad T, Parsania M, Hashemi HR, Puyanfard S.
    Iran J Immunol; 2009 Mar 25; 6(1):22-7. PubMed ID: 19293474
    [Abstract] [Full Text] [Related]

  • 10. A protective role of interleukin-15 in a mouse model for systemic infection with herpes simplex virus.
    Tsunobuchi H, Nishimura H, Goshima F, Daikoku T, Suzuki H, Nakashima I, Nishiyama Y, Yoshikai Y.
    Virology; 2000 Sep 15; 275(1):57-66. PubMed ID: 11017787
    [Abstract] [Full Text] [Related]

  • 11. NK cells contribute to the early clearance of HSV-1 from the lung but cannot control replication in the central nervous system following intranasal infection.
    Reading PC, Whitney PG, Barr DP, Smyth MJ, Brooks AG.
    Eur J Immunol; 2006 Apr 15; 36(4):897-905. PubMed ID: 16552715
    [Abstract] [Full Text] [Related]

  • 12. Phenotypic identification of antigen-dependent and antigen-independent CD8 CTL precursors in the draining lymph node during acute cutaneous herpes simplex virus type 1 infection.
    McNally JM, Dempsey D, Wolcott RM, Chervenak R, Jennings SR.
    J Immunol; 1999 Jul 15; 163(2):675-81. PubMed ID: 10395657
    [Abstract] [Full Text] [Related]

  • 13. Acute morphine administration reduces white blood cells' capability to induce innate resistance against HSV-1 infection in BALB/c mice.
    Jamali A, Bamdad T, Soleimanjahi H, Pakdel FG, Arefian E.
    Neuroimmunomodulation; 2007 Jul 15; 14(1):16-23. PubMed ID: 17700036
    [Abstract] [Full Text] [Related]

  • 14. The efficacy of a DNA vaccine encoding herpes simplex virus type 1 (HSV-1) glycoprotein D in decreasing ocular disease severity following corneal HSV-1 challenge.
    Frye TD, Chiou HC, Hull BE, Bigley NJ.
    Arch Virol; 2002 Sep 15; 147(9):1747-59. PubMed ID: 12209314
    [Abstract] [Full Text] [Related]

  • 15. 4-1BB costimulation enhances HSV-1-specific CD8+ T cell responses by the induction of CD11c+CD8+ T cells.
    Kim YH, Seo SK, Choi BK, Kang WJ, Kim CH, Lee SK, Kwon BS.
    Cell Immunol; 2005 Dec 15; 238(2):76-86. PubMed ID: 16524567
    [Abstract] [Full Text] [Related]

  • 16. The role of donor CD4(+) T cells in the reconstitution of oral immunity by herpes simplex virus type 1 in severe combined immunodeficiency mice.
    Irie H, Aita K, Koyama AH, Fukuda A, Yoshida T, Shiga J.
    J Infect Dis; 2002 Feb 15; 185(4):409-16. PubMed ID: 11865391
    [Abstract] [Full Text] [Related]

  • 17. Role of mucosal immunity in herpes simplex virus infection.
    Kuklin NA, Daheshia M, Chun S, Rouse BT.
    J Immunol; 1998 Jun 15; 160(12):5998-6003. PubMed ID: 9637514
    [Abstract] [Full Text] [Related]

  • 18. Neuroinvasive properties of herpes simplex virus type 1 glycoprotein variants are controlled by the immune response.
    Mitchell BM, Stevens JG.
    J Immunol; 1996 Jan 01; 156(1):246-55. PubMed ID: 8598469
    [Abstract] [Full Text] [Related]

  • 19. Bystander activation of CD4+ T cells accounts for herpetic ocular lesions.
    Gangappa S, Deshpande SP, Rouse BT.
    Invest Ophthalmol Vis Sci; 2000 Feb 01; 41(2):453-9. PubMed ID: 10670475
    [Abstract] [Full Text] [Related]

  • 20. LFA-3 plasmid DNA enhances Ag-specific humoral- and cellular-mediated protective immunity against herpes simplex virus-2 in vivo: involvement of CD4+ T cells in protection.
    Sin JI, Kim J, Dang K, Lee D, Pachuk C, Satishchandran C, Weiner DB.
    Cell Immunol; 2000 Jul 10; 203(1):19-28. PubMed ID: 10915558
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.